MedPath

Lidocaine and Prilocaine

Lidocaine and Prilocaine Cream, USP 2.5%/2.5%

Approved
Approval ID

54198bf6-c93c-42cd-9b2b-63918eb32880

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 8, 2025

Manufacturers
FDA

Alembic Pharmaceuticals Limited

DUNS: 650574663

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine and Prilocaine

PRODUCT DETAILS

NDC Product Code46708-582
Application NumberANDA213923
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateApril 8, 2025
Generic NameLidocaine and Prilocaine

INGREDIENTS (6)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
PEG-54 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine and Prilocaine - FDA Drug Approval Details